Professor of Clinical Medicine (Cardiovascular Medicine); Firm Chief- Coronary Intensive Care Unit (CICU), Internal Medicine; Director, Interventional Cardiology Fellowship Program, Internal Medicine; Medical Director, Coronary Intensive Care Unit, Yale-New Haven Hospital, Yale Medicine; Director, Inpatient Cardiology Services, Yale Medicine
Inpatient cardiovascular services encompass CCU and the step down unit, the Goodyer service (general inpatient cardiology) and the consult service.
The CCU/step-down service, directed by Joseph Brennan, MD, Associate Professor of Medicine, provides full time management for patients with acute coronary syndromes.
The Goodyer service, directed by Lynda Rosenfeld, MD, Associate Professor of Medicine, is dedicated to inpatient management of patients with a wide spectrum of cardiovascular illnesses spectrum of cardiovascular illnesses and their safe transition to outpatient care.
The consult service makes Yale cardiology expertise available to all physicians and patients in the Yale New Haven Hospital.
- Coronary Intensive Care Unit
- Goodyer Service
The 16 bed Coronary Intensive Care Unit (CICU), under the direction of Dr. Joseph Brennan, is an integral component of the busy and diverse clinical in-patient service at Yale-New Haven Hospital and the Yale University School of Medicine. Yale – New Haven Hospital (YNHH) serves as the largest primary care hospital in New Haven, CT as well as a tertiary care center for Connecticut, southern Rhode Island, and parts of New York State.The patients from this extremely large catchment area represent a wide variety of both common and rare cardiovascular disorders and therefore provide a wide – ranging experience and exposure to varying cardiac conditions in a demographically and culturally diverse population.
The CICU provides extremely specialized and integrated care to effectively manage complex cardiovascular disease. Patients presenting with acute myocardial infarction (AMI), hypertensive urgency and emergency, hemodynamically unstable arrhythmias, cardiomyopathies, acute and chronic congestive heart failure, as well as those patients that have undergone complex percutaneous coronary interventions (PCI) or complex arrhythmia ablative procedures, as well as those patients requiring ventricular assist devices (VAD), are housed in the CICU. The CICU has been instrumental in the development and enhancement of the YNHH Therapeutic Hypothermia Protocol for survivors of out- of- hospital cardiac arrest. We expect continued growth in CICU patient volume through several clinical and research initiatives, including our TAVI (Transcatheter Aortic-Valve Implantation) protocol, continued growth of our Carotid Stenting and Peripheral Vascular programs, as well as continued expansion of our Ventricular Assist Device program.
The breadth of clinical exposure in the CICU provides both Internal Medicine, as well as Cardiovascular Medicine trainees unequaled educational opportunities to participate in the care of critically ill patients and the opportunity to provide high quality evidence-based patient care under the auspices of a dedicated teaching attending.
Professor Emeritus of Medicine (Cardiology); Director, Clinical Cardiac Electrophysiology Fellowship Program, Cardiovascular Medicine; Firm Chief, Goodyer Teaching Service, Internal Medicine; Medical Director, HVC Anticoagulation Clinic, Cardiovascular Medicine